Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by NK Cell Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 NK Cell Therapies 1.4.3 NK Cell Directed Antibodies 1.5 Market by Application 1.5.1 Global NK Cell Therapy Market Share by Application: 2020 VS 2026 1.5.2 Cancer 1.5.3 Gastrointestinal Diseases 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 NK Cell Therapy Market Perspective (2015-2026) 2.2 NK Cell Therapy Growth Trends by Regions 2.2.1 NK Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 NK Cell Therapy Historic Market Share by Regions (2015-2020) 2.2.3 NK Cell Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 NK Cell Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key NK Cell Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top NK Cell Therapy Players by Market Size 3.1.1 Global Top NK Cell Therapy Players by Revenue (2015-2020) 3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global NK Cell Therapy Market Concentration Ratio 3.2.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2019 3.3 NK Cell Therapy Key Players Head office and Area Served 3.4 Key Players NK Cell Therapy Product Solution and Service 3.5 Date of Enter into NK Cell Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global NK Cell Therapy Historic Market Size by Type (2015-2020) 4.2 Global NK Cell Therapy Forecasted Market Size by Type (2021-2026) 5 NK Cell Therapy Breakdown Data by Application (2015-2026) 5.1 Global NK Cell Therapy Market Size by Application (2015-2020) 5.2 Global NK Cell Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America NK Cell Therapy Market Size (2015-2020) 6.2 NK Cell Therapy Key Players in North America (2019-2020) 6.3 North America NK Cell Therapy Market Size by Type (2015-2020) 6.4 North America NK Cell Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe NK Cell Therapy Market Size (2015-2020) 7.2 NK Cell Therapy Key Players in Europe (2019-2020) 7.3 Europe NK Cell Therapy Market Size by Type (2015-2020) 7.4 Europe NK Cell Therapy Market Size by Application (2015-2020) 8 China 8.1 China NK Cell Therapy Market Size (2015-2020) 8.2 NK Cell Therapy Key Players in China (2019-2020) 8.3 China NK Cell Therapy Market Size by Type (2015-2020) 8.4 China NK Cell Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan NK Cell Therapy Market Size (2015-2020) 9.2 NK Cell Therapy Key Players in Japan (2019-2020) 9.3 Japan NK Cell Therapy Market Size by Type (2015-2020) 9.4 Japan NK Cell Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia NK Cell Therapy Market Size (2015-2020) 10.2 NK Cell Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia NK Cell Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia NK Cell Therapy Market Size by Application (2015-2020) 11 India 11.1 India NK Cell Therapy Market Size (2015-2020) 11.2 NK Cell Therapy Key Players in India (2019-2020) 11.3 India NK Cell Therapy Market Size by Type (2015-2020) 11.4 India NK Cell Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America NK Cell Therapy Market Size (2015-2020) 12.2 NK Cell Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America NK Cell Therapy Market Size by Type (2015-2020) 12.4 Central & South America NK Cell Therapy Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Nektar Therapeutics 13.1.1 Nektar Therapeutics Company Details 13.1.2 Nektar Therapeutics Business Overview and Its Total Revenue 13.1.3 Nektar Therapeutics NK Cell Therapy Introduction 13.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2015-2020)) 13.1.5 Nektar Therapeutics Recent Development 13.2 Innate Pharma SA 13.2.1 Innate Pharma SA Company Details 13.2.2 Innate Pharma SA Business Overview and Its Total Revenue 13.2.3 Innate Pharma SA NK Cell Therapy Introduction 13.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2015-2020) 13.2.5 Innate Pharma SA Recent Development 13.3 Affimed 13.3.1 Affimed Company Details 13.3.2 Affimed Business Overview and Its Total Revenue 13.3.3 Affimed NK Cell Therapy Introduction 13.3.4 Affimed Revenue in NK Cell Therapy Business (2015-2020) 13.3.5 Affimed Recent Development 13.4 Chipscreen Biosciences 13.4.1 Chipscreen Biosciences Company Details 13.4.2 Chipscreen Biosciences Business Overview and Its Total Revenue 13.4.3 Chipscreen Biosciences NK Cell Therapy Introduction 13.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2015-2020) 13.4.5 Chipscreen Biosciences Recent Development 13.5 Fate Therapeutics 13.5.1 Fate Therapeutics Company Details 13.5.2 Fate Therapeutics Business Overview and Its Total Revenue 13.5.3 Fate Therapeutics NK Cell Therapy Introduction 13.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2015-2020) 13.5.5 Fate Therapeutics Recent Development 13.6 Glycostem Therapeutics 13.6.1 Glycostem Therapeutics Company Details 13.6.2 Glycostem Therapeutics Business Overview and Its Total Revenue 13.6.3 Glycostem Therapeutics NK Cell Therapy Introduction 13.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2015-2020) 13.6.5 Glycostem Therapeutics Recent Development 13.7 Dragonfly Therapeutics 13.7.1 Dragonfly Therapeutics Company Details 13.7.2 Dragonfly Therapeutics Business Overview and Its Total Revenue 13.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction 13.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2015-2020) 13.7.5 Dragonfly Therapeutics Recent Development 13.8 Kiadis Pharma 13.8.1 Kiadis Pharma Company Details 13.8.2 Kiadis Pharma Business Overview and Its Total Revenue 13.8.3 Kiadis Pharma NK Cell Therapy Introduction 13.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2015-2020) 13.8.5 Kiadis Pharma Recent Development 13.9 NantWorks 13.9.1 NantWorks Company Details 13.9.2 NantWorks Business Overview and Its Total Revenue 13.9.3 NantWorks NK Cell Therapy Introduction 13.9.4 NantWorks Revenue in NK Cell Therapy Business (2015-2020) 13.9.5 NantWorks Recent Development 13.10 Nkarta Therapeutics 13.10.1 Nkarta Therapeutics Company Details 13.10.2 Nkarta Therapeutics Business Overview and Its Total Revenue 13.10.3 Nkarta Therapeutics NK Cell Therapy Introduction 13.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2015-2020) 13.10.5 Nkarta Therapeutics Recent Development 13.11 Fortress Biotech 10.11.1 Fortress Biotech Company Details 10.11.2 Fortress Biotech Business Overview and Its Total Revenue 10.11.3 Fortress Biotech NK Cell Therapy Introduction 10.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2015-2020) 10.11.5 Fortress Biotech Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. NK Cell Therapy Key Market Segments Table 2. Key Players Covered: Ranking by NK Cell Therapy Revenue Table 3. Ranking of Global Top NK Cell Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of NK Cell Therapies Table 6. Key Players of NK Cell Directed Antibodies Table 7. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global NK Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global NK Cell Therapy Market Size by Regions (2015-2020) (US$ Million) Table 10. Global NK Cell Therapy Market Share by Regions (2015-2020) Table 11. Global NK Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global NK Cell Therapy Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. NK Cell Therapy Market Growth Strategy Table 17. Main Points Interviewed from Key NK Cell Therapy Players Table 18. Global NK Cell Therapy Revenue by Players (2015-2020) (Million US$) Table 19. Global NK Cell Therapy Market Share by Players (2015-2020) Table 20. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NK Cell Therapy as of 2019) Table 21. Global NK Cell Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players NK Cell Therapy Product Solution and Service Table 24. Date of Enter into NK Cell Therapy Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 27. Global NK Cell Therapy Market Size Share by Type (2015-2020) Table 28. Global NK Cell Therapy Revenue Market Share by Type (2021-2026) Table 29. Global NK Cell Therapy Market Size Share by Application (2015-2020) Table 30. Global NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 31. Global NK Cell Therapy Market Size Share by Application (2021-2026) Table 32. North America Key Players NK Cell Therapy Revenue (2019-2020) (Million US$) Table 33. North America Key Players NK Cell Therapy Market Share (2019-2020) Table 34. North America NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 35. North America NK Cell Therapy Market Share by Type (2015-2020) Table 36. North America NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 37. North America NK Cell Therapy Market Share by Application (2015-2020) Table 38. Europe Key Players NK Cell Therapy Revenue (2019-2020) (Million US$) Table 39. Europe Key Players NK Cell Therapy Market Share (2019-2020) Table 40. Europe NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 41. Europe NK Cell Therapy Market Share by Type (2015-2020) Table 42. Europe NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 43. Europe NK Cell Therapy Market Share by Application (2015-2020) Table 44. China Key Players NK Cell Therapy Revenue (2019-2020) (Million US$) Table 45. China Key Players NK Cell Therapy Market Share (2019-2020) Table 46. China NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 47. China NK Cell Therapy Market Share by Type (2015-2020) Table 48. China NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 49. China NK Cell Therapy Market Share by Application (2015-2020) Table 50. Japan Key Players NK Cell Therapy Revenue (2019-2020) (Million US$) Table 51. Japan Key Players NK Cell Therapy Market Share (2019-2020) Table 52. Japan NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 53. Japan NK Cell Therapy Market Share by Type (2015-2020) Table 54. Japan NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 55. Japan NK Cell Therapy Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players NK Cell Therapy Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players NK Cell Therapy Market Share (2019-2020) Table 58. Southeast Asia NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia NK Cell Therapy Market Share by Type (2015-2020) Table 60. Southeast Asia NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia NK Cell Therapy Market Share by Application (2015-2020) Table 62. India Key Players NK Cell Therapy Revenue (2019-2020) (Million US$) Table 63. India Key Players NK Cell Therapy Market Share (2019-2020) Table 64. India NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 65. India NK Cell Therapy Market Share by Type (2015-2020) Table 66. India NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 67. India NK Cell Therapy Market Share by Application (2015-2020) Table 68. Central & South America Key Players NK Cell Therapy Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players NK Cell Therapy Market Share (2019-2020) Table 70. Central & South America NK Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America NK Cell Therapy Market Share by Type (2015-2020) Table 72. Central & South America NK Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America NK Cell Therapy Market Share by Application (2015-2020) Table 74. Nektar Therapeutics Company Details Table 75. Nektar Therapeutics Business Overview Table 76. Nektar Therapeutics Product Table 77. Nektar Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 78. Nektar Therapeutics Recent Development Table 79. Innate Pharma SA Company Details Table 80. Innate Pharma SA Business Overview Table 81. Innate Pharma SA Product Table 82. Innate Pharma SA Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 83. Innate Pharma SA Recent Development Table 84. Affimed Company Details Table 85. Affimed Business Overview Table 86. Affimed Product Table 87. Affimed Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 88. Affimed Recent Development Table 89. Chipscreen Biosciences Company Details Table 90. Chipscreen Biosciences Business Overview Table 91. Chipscreen Biosciences Product Table 92. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 93. Chipscreen Biosciences Recent Development Table 94. Fate Therapeutics Company Details Table 95. Fate Therapeutics Business Overview Table 96. Fate Therapeutics Product Table 97. Fate Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 98. Fate Therapeutics Recent Development Table 99. Glycostem Therapeutics Company Details Table 100. Glycostem Therapeutics Business Overview Table 101. Glycostem Therapeutics Product Table 102. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 103. Glycostem Therapeutics Recent Development Table 104. Dragonfly Therapeutics Company Details Table 105. Dragonfly Therapeutics Business Overview Table 106. Dragonfly Therapeutics Product Table 107. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 108. Dragonfly Therapeutics Recent Development Table 109. Kiadis Pharma Business Overview Table 110. Kiadis Pharma Product Table 111. Kiadis Pharma Company Details Table 112. Kiadis Pharma Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 113. Kiadis Pharma Recent Development Table 114. NantWorks Company Details Table 115. NantWorks Business Overview Table 116. NantWorks Product Table 117. NantWorks Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 118. NantWorks Recent Development Table 119. Nkarta Therapeutics Company Details Table 120. Nkarta Therapeutics Business Overview Table 121. Nkarta Therapeutics Product Table 122. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 123. Nkarta Therapeutics Recent Development Table 124. Fortress Biotech Company Details Table 125. Fortress Biotech Business Overview Table 126. Fortress Biotech Product Table 127. Fortress Biotech Revenue in NK Cell Therapy Business (2015-2020) (Million US$) Table 128. Fortress Biotech Recent Development Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Global NK Cell Therapy Market Share by Type: 2020 VS 2026 Figure 2. NK Cell Therapies Features Figure 3. NK Cell Directed Antibodies Features Figure 4. Global NK Cell Therapy Market Share by Application: 2020 VS 2026 Figure 5. Cancer Case Studies Figure 6. Gastrointestinal Diseases Case Studies Figure 7. Others Case Studies Figure 8. NK Cell Therapy Report Years Considered Figure 9. Global NK Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global NK Cell Therapy Market Share by Regions: 2020 VS 2026 Figure 11. Global NK Cell Therapy Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global NK Cell Therapy Market Share by Players in 2019 Figure 14. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NK Cell Therapy as of 2019 Figure 15. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2019 Figure 16. North America NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Nektar Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 25. Innate Pharma SA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 27. Affimed Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Affimed Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 29. Chipscreen Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 31. Fate Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 33. Glycostem Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 35. Dragonfly Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 37. Kiadis Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 39. NantWorks Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 41. Nkarta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 43. Fortress Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2015-2020) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Nektar Therapeutics Innate Pharma SA Affimed Chipscreen Biosciences Fate Therapeutics Glycostem Therapeutics Dragonfly Therapeutics Kiadis Pharma NantWorks Nkarta Therapeutics Fortress Biotech